A one-year cost-utility analysis of REBOA versus RTACC for non-compressible torso haemorrhage.
Maxwell S RennaCristiano van ZellerFarah Abu-HijlehCherlyn TongJasmine GambiniMengyao Ma
Published in: Trauma (London, England) (2017)
Although REBOA has not been found to be cost-effective when compared to RTACC, ultimately, clinical experience and expertise should be the main factor in driving the decision over which intervention to prioritise in the emergency context.